# FDA Inspection 824267 - Cardinal Biologicals, Inc. - March 27, 2013

Source: https://www.keypedia.com/records/fda_inspections/cardinal-biologicals-inc/ae01f5ef-8f9a-4b42-a8c6-eefa15ff16b1
Source feed: FDA_Inspections

> FDA Inspection 824267 for Cardinal Biologicals, Inc. on March 27, 2013. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 824267
- Company Name: Cardinal Biologicals, Inc.
- Inspection Date: 2013-03-27
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1269612 - 2025-05-09](https://www.keypedia.com/records/fda_inspections/cardinal-biologicals-inc/f6014819-a3b3-4cf9-9289-5ff24943e840)
- [FDA Inspection 1269612 - 2025-05-09](https://www.keypedia.com/records/fda_inspections/cardinal-biologicals-inc/a3631d7e-0c07-4e48-b876-ab2582afed63)
- [FDA Inspection 1041210 - 2018-02-06](https://www.keypedia.com/records/fda_inspections/cardinal-biologicals-inc/9ab8b0a5-4b06-4af9-9acd-1e0fac777f01)
- [FDA Inspection 974514 - 2016-05-24](https://www.keypedia.com/records/fda_inspections/cardinal-biologicals-inc/caf18e3d-88e1-4bdb-a266-27596974db8d)
- [FDA Inspection 824267 - 2013-03-27](https://www.keypedia.com/records/fda_inspections/cardinal-biologicals-inc/4f2f6060-84d4-4ba9-9054-e6f60be1bc98)

Company: https://www.keypedia.com/companies/cardinal-biologicals-inc/0afeaaa1-90e2-4642-9bf5-95bc060e9127

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d